Corneal reconstruction by stem cells and bioengineering

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Biomaterials Science

Background:

• Over 300 million people globally experience visual impairment, with corneal diseases being a significant cause.
• Severe ocular surface diseases lead to blindness in ten million individuals, predominantly in developing nations.
• The demand for human corneal tissue for transplantation far surpasses the available supply, necessitating alternative solutions.

Purpose of the Study:

• To explore novel methods for corneal reconstruction beyond traditional tissue donation.
• To investigate the potential of xenotransplantation and stem cell-based therapies for treating blinding corneal diseases.
• To assess the feasibility of using engineered biocompatible tissue equivalents for corneal repair.

Main Methods:

• Review of current and emerging treatments for blinding ocular surface diseases.
• Discussion of xenotransplantation using genetically modified pig corneas or cells.
• Exploration of limbal stem cell transplantation techniques.
• Preclinical evaluation of synthetic corneal tissue guiding human corneal stromal stem cells.

Main Results:

• Synthetic corneal tissue has demonstrated the ability to guide human corneal stromal stem cells to form native-like stroma.
• Limbal stem cell transplantation shows promise in clinical studies for restoring corneal transparency.
• Engineered biocompatible tissue equivalents represent a potential avenue for large-quantity biomaterial production.

Conclusions:

• Advancements in stem cell technology and tissue engineering offer promising solutions for corneal reconstruction.
• Synthetic biomaterials hold potential for addressing the critical shortage of donor corneal tissue.
• Increased familiarity with laboratory science methods among clinical ophthalmologists is crucial for advancing patient care.